United Therapeutics
Jul 03, 2020
Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline
As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, healthcare spending, improved R&D, and discovery of novel targets. Small cell lung cancer (SCLC) or Small cell lung carcinoma is an aggressi...
Read More...
Feb 04, 2020
First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares Soares
The US FDA has given its recommendation to the Aimmune Therapeutics’ drug, Palforzia, the first-ever treatment for Peanut Allergy. Palforzia is an oral immunotherapy, set to address the unmet needs in the Peanut market, reducing the incidence and severity of allergic reactions, including anaphylaxis, which may ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
